Who is sponsoring NCT03726684?

NCT03726684 is sponsored by University of Zurich.

What drugs are being tested in NCT03726684?

Interventions in NCT03726684: Coding strategy for cochlear implants.

What condition does NCT03726684 study?

NCT03726684 studies Hearing Loss, Complete.

Is NCT03726684 still recruiting?

NCT03726684 is currently completed. Last updated 4 November 2020.

Last reviewed 2020-11-04 · How we verify

NCT03726684: EBCS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of a Bio-inspired Coding Strategy for Cochlear Implant Users

Completed NA Last updated 4 November 2020

What this trial tests

NA trial testing Coding strategy for cochlear implants in Hearing Loss, Complete in 10 participants. Completed in 31 October 2018.

Timeline

2 July 2018

Primary endpoint
31 October 2018

31 October 2018

Quick facts

Lead sponsor	University of Zurich
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	10
Start date	2 July 2018
Primary completion	31 October 2018
Estimated completion	31 October 2018
Sites	1 location across Switzerland

Drugs / interventions tested

Coding strategy for cochlear implants

Conditions studied

Hearing Loss, Complete — all drugs for Hearing Loss, Complete →

Sponsor

University of Zurich

Who can join

Adults 18 to 80, any sex, with Hearing Loss, Complete. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will determine the facilitation, refractoriness and spatial spread effects of auditory nerve fiber responses to electrical stimulation via a cochlear implant. The performance of CI users in melody contour and speech recognition in noise tests with their own clinical sound processor and a MATLAB implementation of their coding strategy will be compared and a bioinspired coding strategy will be evaluated in comparison with the conventional ACE coding strategy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Zurich trials

Trials by the same sponsor.

NCT07485699 — Soy Processing and Food Allergy · NA · not yet recruiting
NCT07516912 — Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland · not yet recruiting
NCT07473115 — Individualized Analgesia in the Intensive Care Unit With a New Pain Assessment Bundle and Protocolized Analgesia Adjustm · not yet recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT06481982 — Value of Advanced MRI Techniques in the Assessment of Endometriosis · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03726684 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Zurich
Last refreshed: 4 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03726684.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing